Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 201

1.

Prescribing statins: the real issues.

Hamilton-Craig IR.

Med J Aust. 2014 May 5;200(8):440-1. No abstract available.

PMID:
24794593
2.

Cardiology patient page. Statin intolerance.

Fitchett DH, Hegele RA, Verma S.

Circulation. 2015 Mar 31;131(13):e389-91. doi: 10.1161/CIRCULATIONAHA.114.013189. No abstract available.

3.

Is it appropriate to make statins available over the counter? The argument against the appropriateness of over-the-counter statins.

Barter PJ, Rye KA.

Circulation. 2006 Sep 19;114(12):1315-20; discussion 1320. No abstract available.

4.

[How do you manage muscle pain?"].

Klein F.

MMW Fortschr Med. 2016 Feb 18;158(3):19. doi: 10.1007/s15006-016-7788-x. German. No abstract available.

PMID:
27119671
5.

Fluvastatin: efficacy and safety in reducing cardiac events.

Chan MY, Lee CH.

Expert Opin Pharmacother. 2005 Sep;6(11):1883-95. Review.

PMID:
16144508
6.

Rosuvastatin: a risk-benefit assessment for intensive lipid lowering.

Ferdinand KC.

Expert Opin Pharmacother. 2005 Sep;6(11):1897-910. Review.

PMID:
16144509
7.

Statins and low-density lipoprotein cholesterol levels.

Cohen JS.

Am J Med. 2003 Jul;115(1):74-5; author reply 75-6. No abstract available.

PMID:
12867244
8.

Do patients on statins also need niacin?

Jones KW.

JAAPA. 2013 Jul;26(7):9-10.

PMID:
23923280
9.

Statins: putting the benefit/risk into perspective.

Shepherd J.

Int J Clin Pract Suppl. 2003 Oct;(137):27-33. Review. No abstract available.

PMID:
14649699
10.

JAMA patient page. Statins.

Sugerman DT, Livingston EH, Lynm C.

JAMA. 2013 Apr 3;309(13):1419. doi: 10.1001/jama.2013.3041. No abstract available.

PMID:
23549589
11.

Statins in patients with chronic kidney disease: evidence from systematic reviews and randomized clinical trials.

Navaneethan SD, Pansini F, Strippoli GF.

PLoS Med. 2006 May;3(5):e123. Epub 2006 May 30. Review. No abstract available.

12.

Statins work around the world.

Postmus I, Trompet S, Wouter Jukema J.

Curr Med Res Opin. 2013 Jul;29(7):747-9. doi: 10.1185/03007995.2013.799392. Epub 2013 May 10. No abstract available.

PMID:
23614629
13.

The influence of statin characteristics on their safety and tolerability.

De Angelis G.

Int J Clin Pract. 2004 Oct;58(10):945-55. Review.

PMID:
15587774
14.

[Are cholesterol target values still current?].

Fue├čl HS, Stiefelhagen P.

MMW Fortschr Med. 2015 Sep 10;157(15):39. doi: 10.1007/s15006-015-3469-4. German. No abstract available.

PMID:
26349720
15.

Inhibition of xanthine oxidase to prevent statin-induced myalgia and rhabdomiolysis.

Alis R, Sanchis-Gomar F, Risso-Ballester J, Perez-Quilis C, Cortell-Ballester J, Romagnoli M, Blesa JR, Emanuele E.

Atherosclerosis. 2015 Mar;239(1):38-42. doi: 10.1016/j.atherosclerosis.2014.12.055. Epub 2014 Dec 31.

PMID:
25568951
16.

The safety of statins in children.

Lamaida N, Capuano E, Pinto L, Capuano E, Capuano R, Capuano V.

Acta Paediatr. 2013 Sep;102(9):857-62. doi: 10.1111/apa.12280. Epub 2013 May 15. Review.

PMID:
23631461
17.

Growing body of evidence shows benefits of aggressive lipid management in high-risk patients.

[No authors listed]

Am J Manag Care. 2002 Jul;Suppl Symposium Reporter:3, 5. No abstract available.

19.

[Hyperlipidemia: decreasing lipid values and effects of statins].

Mathes P.

Z Kardiol. 2002;91 Suppl 2:25-9. Review. German. No abstract available.

PMID:
12436762
20.

[Comment from tHE cardiologic-angiologic viewpoint].

Rosemann A.

Praxis (Bern 1994). 2011 Jul 6;100(14):857-8. doi: 10.1024/1661-8157/a000585. German. No abstract available.

PMID:
21732298

Supplemental Content

Support Center